Continuous Glucose Monitoring-Based Composite Metrics: A Review and Assessment of Performance in Recent-Onset and Long-Duration Type 1 Diabetes
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Continuous Glucose Monitoring-Based Composite Metrics: A Review and Assessment of Performance in Recent-Onset and Long-Duration Type 1 Diabetes
Authors
Keywords
-
Journal
Diabetes Technology & Therapeutics
Volume -, Issue -, Pages -
Publisher
Mary Ann Liebert Inc
Online
2023-04-03
DOI
10.1089/dia.2022.0563
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Complications of diabetes and metrics of glycaemic management derived from continuous glucose monitoring
- (2022) Michael Yapanis et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Investigating the efficacy of baricitinib in new onset type 1 diabetes mellitus (BANDIT)—study protocol for a phase 2, randomized, placebo controlled trial
- (2022) M. Waibel et al. Trials
- A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings
- (2022) David C. Klonoff et al. Journal of diabetes science and technology
- Essential Continuous Glucose Monitoring Metrics: The Principal Dimensions of Glycemic Control in Diabetes
- (2022) Eslam Montaser et al. Diabetes Technology & Therapeutics
- Efficacy of a Hybrid Closed-Loop Solution in Patients With Excessive Time in Hypoglycaemia: A Post Hoc Analysis of Trials With DBLG1 System
- (2022) Pierre-Yves Benhamou et al. Journal of diabetes science and technology
- Real-world use of a new hybrid closed-loop improves glycemic control in youth with type 1 diabetes
- (2021) Laurel H Messer et al. Diabetes Technology & Therapeutics
- Quality of Glycemic Control: Assessment Using Relationships Between Metrics for Safety and Efficacy
- (2021) David Rodbard Diabetes Technology & Therapeutics
- Closed-Loop Insulin Delivery Versus Sensor-Augmented Pump Therapy in Older Adults With Type 1 Diabetes (ORACL): A Randomized, Crossover Trial
- (2021) Sybil A. McAuley et al. DIABETES CARE
- A Review of Continuous Glucose Monitoring-Based Composite Metrics for Glycemic Control
- (2020) Michelle Nguyen et al. Diabetes Technology & Therapeutics
- Assessment of Glucose Control Metrics by Discriminant Ratio
- (2020) Vanessa Moscardó et al. Diabetes Technology & Therapeutics
- Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
- (2019) Tadej Battelino et al. DIABETES CARE
- Role of Composite Glycemic Indices: A Comparison of the Comprehensive Glucose Pentagon Across Diabetes Types and HbA1c Levels
- (2019) Suresh Rama Chandran et al. Diabetes Technology & Therapeutics
- Temporal case-based reasoning for type 1 diabetes mellitus bolus insulin decision support
- (2018) Daniel Brown et al. ARTIFICIAL INTELLIGENCE IN MEDICINE
- Metrics to Evaluate Quality of Glycemic Control: Comparison of Time in Target, Hypoglycemic, and Hyperglycemic Ranges with “Risk Indices”
- (2018) David Rodbard Diabetes Technology & Therapeutics
- Glycemic Variability Percentage: A Novel Method for Assessing Glycemic Variability from Continuous Glucose Monitor Data
- (2018) Thomas A. Peyser et al. Diabetes Technology & Therapeutics
- Glycaemic variability in diabetes: clinical and therapeutic implications
- (2018) Antonio Ceriello et al. Lancet Diabetes & Endocrinology
- The Relationship of Hemoglobin A1C to Time-in-Range in Patients with Diabetes
- (2018) Robert A. Vigersky et al. Diabetes Technology & Therapeutics
- Measures of Glycemic Variability in Type 1 Diabetes and the Effect of Real-Time Continuous Glucose Monitoring
- (2016) Ahmed H. El-Laboudi et al. Diabetes Technology & Therapeutics
- Q-Score: development of a new metric for continuous glucose monitoring that enables stratification of antihyperglycaemic therapies
- (2015) Petra Augstein et al. BMC Endocrine Disorders
- Evaluation of the Mean Absolute Glucose Change as a Measure of Glycemic Variability Using Continuous Glucose Monitoring Data
- (2013) Klaus-Dieter Kohnert et al. Diabetes Technology & Therapeutics
- Normal Reference Range for Mean Tissue Glucose and Glycemic Variability Derived from Continuous Glucose Monitoring for Subjects Without Diabetes in Different Ethnic Groups
- (2011) Nathan R. Hill et al. Diabetes Technology & Therapeutics
- Glucose variability is associated with intensive care unit mortality*
- (2010) Jeroen Hermanides et al. CRITICAL CARE MEDICINE
- Statistical Tools to Analyze Continuous Glucose Monitor Data
- (2009) William Clarke et al. Diabetes Technology & Therapeutics
- Improved Quality of Glycemic Control and Reduced Glycemic Variability with Use of Continuous Glucose Monitoring
- (2009) David Rodbard et al. Diabetes Technology & Therapeutics
- The “Glucose Pentagon”: Assessing Glycemic Control of Patients with Diabetes Mellitus by a Model Integrating Different Parameters from Glucose Profiles
- (2009) Andreas Thomas et al. Diabetes Technology & Therapeutics
- Interpretation of Continuous Glucose Monitoring Data: Glycemic Variability and Quality of Glycemic Control
- (2009) David Rodbard Diabetes Technology & Therapeutics
- FRAX™ and the assessment of fracture probability in men and women from the UK
- (2008) J. A. Kanis et al. OSTEOPOROSIS INTERNATIONAL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search